Origin Therapeutics Holdings (XCNQ:ORIG) Other Income (Expense) : C$-2.25 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Other Income (Expense)?

Origin Therapeutics Holdings's other income expense for the Origin Therapeutics Holdings's pretax income for the three months ended in Jun. 2023 was C$-0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2023 was C$-2.25 Mil.

Origin Therapeutics Holdings Other Income (Expense) Historical Data

The historical data trend for Origin Therapeutics Holdings's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Other Income (Expense) Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Other Income (Expense)

-0.46

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Other Income (Expense)	Get a 7-Day Free Trial				-0.13	-0.25	-0.02	-1.97	-

Origin Therapeutics Holdings Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.25 Mil.

Origin Therapeutics Holdings (XCNQ:ORIG) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.